Using the power of Portuguese R&D to drive the drug development space


VectorB2B is a Portuguese company that joins forces of four academic and three in-

dustrial institutions to provide a unique 360° service portfolio in drug discovery and de-

velopment – from molecule to man. Biotech or pharma companies as well as academic

clients will profit from VectorB2B‘s high added-value project design and its innovative

R&D solutions that go beyond the range of conventional CROs or CMOs.

Building on the combined scientific, clinical and business expertise of its seven units,

VectorB2B operates at the forefront of international biological drug/target discovery, de-

velopment and evaluation. Our core areas of expertise include infection, ophthalmology,

central nervous system and oncology, reaching out for other medical fields such as car-

diovascular diseases, rheumatology, or auto-immune diseases.


Our services: creating value along the complete drug discovery & development chain

VectorB2B offers a unique service portfolio for all steps in drug discovery and drug

development. We not only provide a comprehensive, custom-tailored project plan for

each client but we also act as accompanying partner – from bench to bed.

Select the support according to your needs:








There are two parts to the Festival of Biologics: four conferences covering Antibodies, Immunotherapy, Biosimilars and Clinical Trials and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.